Literature DB >> 18414044

The oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry.

Fionnuala Morrish1, Nicola Neretti, John M Sedivy, David M Hockenbery.   

Abstract

The c-myc proto-oncogene is rapidly activated by serum and regulates genes involved in metabolism and cell cycle progression. This gene is thereby uniquely poised to coordinate both the metabolic and cell cycle regulatory events required for cell cycle entry. However, this function of Myc has not been evaluated. Using a rat fibroblast model of isogenic cell lines, myc(-/-), myc(+/-), myc(+/+) and myc(-/-) cells with an inducible c-myc transgene (mycER), we show that the Myc protein programs cells to utilize both oxidative phosphorylation and glycolysis to drive cell cycle progression. We demonstrate this coordinate regulation of metabolic networks is essential, as specific inhibitors of these pathways block Myc-induced proliferation. Metabolic events temporally correlated with cell cycle entry include increased oxygen consumption, mitochondrial function, pyruvate and lactate production, and ATP generation. Treatment of normal cells with inhibitors of oxidative phosphorylation recapitulates the myc(-/-) phenotype, resulting in impaired cell cycle entry and reduced metabolism. Combined with a kinetic expression profiling analysis of genes linked to mitochondrial function, our study indicates that Myc's ability to coordinately regulate the mitochondrial metabolic network transcriptome is required for rapid cell cycle entry. This function of Myc may underlie the pervasive presence of Myc in many human cancers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18414044      PMCID: PMC2518168          DOI: 10.4161/cc.7.8.5739

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  46 in total

1.  Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc.

Authors:  R C Osthus; H Shim; S Kim; Q Li; R Reddy; M Mukherjee; Y Xu; D Wonsey; L A Lee; C V Dang
Journal:  J Biol Chem       Date:  2000-07-21       Impact factor: 5.157

2.  Third-generation human mitochondria-focused cDNA microarray and its bioinformatic tools for analysis of gene expression.

Authors:  Xueyan Bai; Jun Wu; Qiuyang Zhang; Salvatore Alesci; Irini Manoli; Marc R Blackman; George P Chrousos; Allan L Goldstein; Owen M Rennert; Yan A Su
Journal:  Biotechniques       Date:  2007-03       Impact factor: 1.993

3.  Sequential serum-dependent activation of CREB and NRF-1 leads to enhanced mitochondrial respiration through the induction of cytochrome c.

Authors:  R P Herzig; S Scacco; R C Scarpulla
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

4.  Novel fluorescent technology platform for high throughput cytotoxicity and proliferation assays.

Authors:  M Wodnicka; R D Guarino; J J Hemperly; M R Timmins; D Stitt; J B Pitner
Journal:  J Biomol Screen       Date:  2000-06

5.  Genome-wide functional analysis of human cell-cycle regulators.

Authors:  Mridul Mukherji; Russell Bell; Lubica Supekova; Yan Wang; Anthony P Orth; Serge Batalov; Loren Miraglia; Dieter Huesken; Joerg Lange; Christopher Martin; Sudhir Sahasrabudhe; Mischa Reinhardt; Francois Natt; Jonathan Hall; Craig Mickanin; Mark Labow; Sumit K Chanda; Charles Y Cho; Peter G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-25       Impact factor: 11.205

6.  Global mapping of c-Myc binding sites and target gene networks in human B cells.

Authors:  Karen I Zeller; XiaoDong Zhao; Charlie W H Lee; Kuo Ping Chiu; Fei Yao; Jason T Yustein; Hong Sain Ooi; Yuriy L Orlov; Atif Shahab; How Choong Yong; Yutao Fu; Zhiping Weng; Vladimir A Kuznetsov; Wing-Kin Sung; Yijun Ruan; Chi V Dang; Chia-Lin Wei
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-08       Impact factor: 11.205

7.  HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity.

Authors:  Huafeng Zhang; Ping Gao; Ryo Fukuda; Ganesh Kumar; Balaji Krishnamachary; Karen I Zeller; Chi V Dang; Gregg L Semenza
Journal:  Cancer Cell       Date:  2007-05       Impact factor: 31.743

8.  Three members of the human pyruvate dehydrogenase kinase gene family are direct targets of the peroxisome proliferator-activated receptor beta/delta.

Authors:  Tatjana Degenhardt; Anna Saramäki; Marjo Malinen; Markus Rieck; Sami Väisänen; Anne Huotari; Karl-Heinz Herzig; Rolf Müller; Carsten Carlberg
Journal:  J Mol Biol       Date:  2007-07-19       Impact factor: 5.469

9.  Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1.

Authors:  Jung-whan Kim; Ping Gao; Yen-Chun Liu; Gregg L Semenza; Chi V Dang
Journal:  Mol Cell Biol       Date:  2007-09-04       Impact factor: 4.272

10.  Gamma-glutamylcysteine synthetase mediates the c-Myc-dependent response to antineoplastic agents in melanoma cells.

Authors:  Barbara Benassi; Gabriella Zupi; Annamaria Biroccio
Journal:  Mol Pharmacol       Date:  2007-07-12       Impact factor: 4.436

View more
  71 in total

Review 1.  Stable isotope-resolved metabolomics and applications for drug development.

Authors:  Teresa W-M Fan; Pawel K Lorkiewicz; Katherine Sellers; Hunter N B Moseley; Richard M Higashi; Andrew N Lane
Journal:  Pharmacol Ther       Date:  2011-12-23       Impact factor: 12.310

2.  Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction.

Authors:  David R Wise; Ralph J DeBerardinis; Anthony Mancuso; Nabil Sayed; Xiao-Yong Zhang; Harla K Pfeiffer; Ilana Nissim; Evgueni Daikhin; Marc Yudkoff; Steven B McMahon; Craig B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-24       Impact factor: 11.205

3.  Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer.

Authors:  John T Cunningham; Melissa V Moreno; Alessia Lodi; Sabrina M Ronen; Davide Ruggero
Journal:  Cell       Date:  2014-05-22       Impact factor: 41.582

4.  GABP transcription factor (nuclear respiratory factor 2) is required for mitochondrial biogenesis.

Authors:  Zhong-Fa Yang; Karen Drumea; Stephanie Mott; Junling Wang; Alan G Rosmarin
Journal:  Mol Cell Biol       Date:  2014-06-23       Impact factor: 4.272

5.  Kinetic profiling of the c-Myc transcriptome and bioinformatic analysis of repressed gene promoters.

Authors:  Chui-Sun Yap; Abigail L Peterson; Gastone Castellani; John M Sedivy; Nicola Neretti
Journal:  Cell Cycle       Date:  2011-07-01       Impact factor: 4.534

Review 6.  Metabolic effects of signal transduction inhibition in cancer assessed by magnetic resonance spectroscopy.

Authors:  Siver Andreas Moestue; Olav Engebraaten; Ingrid Susann Gribbestad
Journal:  Mol Oncol       Date:  2011-04-23       Impact factor: 6.603

7.  Akt and c-Myc differentially activate cellular metabolic programs and prime cells to bioenergetic inhibition.

Authors:  Yongjun Fan; Kathleen G Dickman; Wei-Xing Zong
Journal:  J Biol Chem       Date:  2009-12-17       Impact factor: 5.157

Review 8.  Rethinking the Warburg effect with Myc micromanaging glutamine metabolism.

Authors:  Chi V Dang
Journal:  Cancer Res       Date:  2010-01-19       Impact factor: 12.701

9.  Glucose regulates the intrinsic inflammatory response of the heart to surgically induced hypothermic ischemic arrest and reperfusion.

Authors:  Ahmed S Bux; Merry L Lindsey; Hernan G Vasquez; Heinrich Taegtmeyer; Romain Harmancey
Journal:  Physiol Genomics       Date:  2016-12-09       Impact factor: 3.107

10.  c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry.

Authors:  F Morrish; N Isern; M Sadilek; M Jeffrey; D M Hockenbery
Journal:  Oncogene       Date:  2009-05-18       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.